Study Number …………..
A 1 year BOSUstudy into dysthyroid optic neuropathy;
epidemiology, presenting features and current management.
Please complete this initial questionnaire using information gathered from the patient's first presentation with dysthyroid optic neuropathy (DON).
Patient details
1aHospital number______
1bFirst half of postcode______
1cMonth and year of birth (mm/yyyy)_____/______
1dGenderMaleFemale
1eEthnicity
White / Asian or Asian British / Black or Black British / Chinese / Mixed Race / Other ethnic group British
Irish
Other (please specify) / Indian
Pakistani
Bangladeshi
Other (please specify) / Caribbean
African
Other (please specify) / Chinese
Other (please specify) / White & Black Caribbean
White & Black African
White & Asian
Other (please specify) / Other (please specify)
Medical, drug and social history
2aWhat was the patients thyroid status?HypothyroidHyperthyroid
EuthyroidNot Known
2bPlease tick all current thyroid medicationsNo thyroid medication
ThyroxineCarbimazole
PropylthiouracilNot known
2cHad the patient received radioactive iodineYesNo
in the past 12 months?
Not known
2dWhat was the patients smoking status?Current smoker Never smoked
Ex SmokerNot known
Graves orbitopathy: features at presentation
3aDate of diagnosis of DON______/______(mm / yyyy)
3bDate of first assessment at your______/______(mm / yyyy)centre if diagnosis made elsewhere
RightLeft
3cWhich eye(s) were affected by DON?
3dWhen the patient presented with DON whatRightLeft
symptoms did they describe?(tick all that apply)
Blurred vision
Awareness of field defect / scotoma Awareness of a change in colour vision
No symptoms
Not known: they presented elsewhere
3eBest corrected acuity (at presentation)______
Method = Snellen LogMar Other
3fColour vision(correct / total tested)______
Method = Ishihara HRR Other
RightLeft
3gProptosis______
Inter canthal distance ______
3hDid the patient have vertical diplopia or upgazeYesYes
restriction?
NoNo
Not KnownNot known
3jRegardingpresentation, please tick the most appropriate response for each eye.
Sign / Right / LeftYes / Equivocal / No / Yes / Equivocal / No
Chemosis
RAPD
Optic disc swelling
Optic atrophy
Choroidal folds
3kWereany additional investigationsperformedto clarify DON?If “No” then proceed directly to question 3m. If “yes” then please simply “tick” to complete the table.
RIGHT EYE / LEFT EYEInvestigation
performed? / Normal / Abnormal
due to
DON / Abnormal:
for other
reasons / Normal / Abnormal
due to
DON / Abnormal:
for other
reasons
Perimetry
VEP
CT orbits
MRI orbits
Other investigation
……………..
(specify)
3mDoes the patient have another conditioncontributing to visual loss?For each eye please tick “no” or specify condition and eye. (there may be several)
RightLeft
nono
GlaucomaGlaucoma
AMDAMD
CataractCataract
Diabetes Diabetes
Other(specify)______Other(specify)______
3nDo you believe that DON is the primarycause of visual loss?
(please tick one response per eye)
RightLeft
YesYes
NoNo
Nosignificant visual loss No significantvisual loss
INITIAL TREATMENT
Question 4only concernsthe INITIAL managementinitiatedor planned in your centre
4a.Please tick all treatments for DON initiated in the first 72 hoursfollowing diagnosis / referral. If radiotherapy is planned as part of primary management then please tick last box.
IV Methylprednisolone ______specify regime for first 2 weeks
(e.g. 1g x3 then further 1 g at 1 week)
Oral prednisolone______specify regime for first 2 weeks
Other immunosuppressive______specify
Orbital bony decompression______
(specifywhich side (R/L), and which walls removed)
Other treatment ______specify
Scheduled orbital radiotherapy
4bDid patient morbidity influence your decisionYes ______
regarding the management of DON?specify what
(eg unfit for surgery / diabetes etc)No
4cDid you refer the patient to another unit?Yes ______
specify where
No
THANK-YOU FOR TAKING THE TIME TO COMPLETE THIS QUESTIONNAIRE
Please post your response to Dr Yun Wong,
C/O Miss Lucy Clarke, Orbital Surgeon, Eye department, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP